Korean J Radiol.  2008 Apr;9(2):140-147. 10.3348/kjr.2008.9.2.140.

Radiofrequency Ablation Using a Monopolar Wet Electrode for the Treatment of Inoperable Non-Small Cell Lung Cancer: a Preliminary Report

• Jin GY
• Han YM
• Lee YS
• Lee YC

• KMID: 1098193
• DOI: http://doi.org/10.3348/kjr.2008.9.2.140

Abstract

OBJECTIVE
To assess the technical feasibility and complications of radiofrequency ablation (RFA) using a monopolar wet electrode for the treatment of inoperable non-small cell lung malignancies. MATERIALS AND METHODS: Sixteen patients with a non-small cell lung malignancy underwent RFA under CT guidance. All the patients were non-surgical candidates, with mean maximum tumor diameters ranging from 3 to 6 cm (mean: 4.6 +/- 1.1 cm). A single 16-gauge open-perfused electrode with a 2 cm exposed tip was used for the procedure. A 0.9% NaCl saline solution was used as the perfusion liquid with the flow adjusted to 30 mL/h. The radiofrequency energy was applied for 10-40 minutes. The response to RFA was evaluated by performing contrast-enhanced CT immediately after RFA, one month after treatment and then every three months thereafter. RESULTS: Technical failure was observed in six (37.5%) of 16 patients: intractable pain (n = 2) and non-stop coughing (n = 4). The mean follow-up interval was 15 +/- 8 months (range: 9-31 months). The mean maximum ablated diameter in the technically successful group of patients ranged from 3.5 to 7.5 cm (mean 5.1 +/- 1.3 cm). Complete necrosis was attained for eight (80%) of 10 lesions, and partial necrosis was achieved for two lesions. There were two major complications (2/10, 20%) encountered: a hemothorax (n = 1) and a bronchopleural fistula (n = 1). CONCLUSION: Although RFA using a monopolar wet electrode can create a large ablation zone, it is associated with a high rate of technical failure when used to treat inoperable non-small cell lung malignancies.

Keyword

Radiofrequency (RF) ablation; Lung neoplasm; Lung, interventional procedure; Lung, CT

MeSH Terms

Adult
Aged
Carcinoma, Non-Small-Cell Lung/radiography/*surgery
Catheter Ablation/adverse effects/*instrumentation
Feasibility Studies
Humans
Lung/pathology
Lung Neoplasms/radiography/*surgery
Middle Aged
Necrosis
Tomography, X-Ray Computed

Figure

• 

  Fig. 1 73-year-old woman with lung cancer (adenocarcinoma) in the right middle lobe. A. Before radiofrequency ablation, contrast-enhanced CT scans showed 3-cm, triangular-shaped, enhanced mass in right middle lobe of lung. B. Monopolar electrode was inserted once within lung mass. C. Immediately after radiofrequency ablation, ablated zone showed almost no enhancement on contrast-enhanced CT scans and this was judged as complete ablation. D. Two years later, contrast-enhanced CT scans revealed small subpleural nodule, such as fibrotic nodule, at previous ablated zone.

• 

  Fig. 2 40-year-old man with lung cancer (adenocarcinoma) in right upper lobe. After undergoing radiofrequency ablation, patient received repeated chemotherapy and radiotherapy as treatment response was only partial ablation. A. Before radiofrequency ablation, contrast-enhanced CT scans showed 6 cm, lobulated contoured, enhanced mass in right upper lobe of lung. B. During radiofrequency ablation, monopolar electrode was inserted twice into center of mass. C. Immediately after radiofrequency ablation, contrast-enhanced CT scans showed peripheral, mildly enhanced rim outside ablated zone of lung cancer (arrow). D. Ten months later, size of ablated zone decreased in diameter (3 cm) and radiation pneumonia in right upper lobe was observed on contrast-enhanced CT. However, patient died from acute respiratory distress syndrome.

Reference

1. Jin GY, Lee JM, Lee YC, Han YM, Lim YS. Primary and secondary lung malignancies treated with percutaneous radiofrequency ablation: evaluation with follow-up helical CT. AJR Am J Roentgenol. 2004. 183:1013–1020.

2. Jin GY, Lee JM, Lee YC, Han YM. Acute cerebral infarction after radiofrequency ablation of an atypical carcinoid pulmonary tumor. AJR Am J Roentgenol. 2004. 182:990–992.

3. Belfiore G, Moggio G, Tedeschi E, Greco M, Cioffi R, Cincotti F, et al. CT-guided radiofrequency ablation: a potential complementary therapy for patients with unresectable primary lung cancer - a preliminary report of 33 patients. AJR Am J Roentgenol. 2004. 183:1003–1011.

4. Lee JM, Jin GY, Goldberg SN, Lee YC, Chung GH, Han YM, et al. Percutaneous radiofrequency ablation for inoperable non-small cell lung cancer and metastases: preliminary report. Radiology. 2004. 230:125–134.

5. Steinke K, King J, Glenn DW, Morris DL. Percutaneous radiofrequency ablation of lung tumors with expandable needle electrodes: tips from preliminary experience. AJR Am J Roentgenol. 2004. 183:605–611.

6. Gadaleta C, Mattioli V, Colucci G, Cramarossa A, Lorusso V, Canniello E, et al. Radiofrequency ablation of 40 lung neoplasms: preliminary results. AJR Am J Roentgenol. 2004. 183:361–368.

7. Diederich S, Hosten N. Percutaneous ablation of pulmonary tumors: state-of-the-art 2004. Radiologe. 2004. 44:658–662.

8. Yasui K, Kanazawa S, Sano Y, Fujiwara T, Kagawa S, Mimura H, et al. Thoracic tumors treated with CT-guided radiofrequency ablation: initial experience. Radiology. 2004. 231:850–857.

9. Steinke K, Glenn D, King J, Clark W, Zhao J, Clingan P, et al. Percutaneous imaging-guided radiofrequency ablation in patients with colorectal pulmonary metastases: 1-year follow-up. Ann Surg Oncol. 2004. 11:207–212.

10. Kang S, Luo R, Liao W, Wu H, Zhang X, Meng Y. Single group study to evaluate the feasibility and complications of radiofrequency ablation and usefulness of post treatment position emission tomography in lung tumours. World J Surg Oncol. 2004. 2:30.

11. Burdio F, Guemes A, Burdio JM, Navarro A, Sousa R, Castiella T, et al. Bipolar saline-enhanced electrode for radiofrequency ablation: results of experimental study of in vivo porcine liver. Radiology. 2003. 229:447–456.

12. Lee JM, Han JK, Kim SH, Sohn KL, Lee KH, Ah SK, et al. A comparative experimental study of the in-vitro efficiency of hypertonic saline-enhanced hepatic bipolar and monopolar radiofrequency ablation. Korean J Radiol. 2003. 4:163–169.

13. Burdio F, Guemes A, Burdio JM, Castiella T, De Gregorio MA, Lozano R, et al. Hepatic lesion ablation with bipolar saline-enhanced radiofrequency in the audible spectrum. Acad Radiol. 1999. 6:680–686.

14. Lee JM, Kim SW, Li CA, Youk JH, Kim YK, Jin Z, et al. Saline-enhanced radiofrequency thermal ablation of the lung: a feasibility study in rabbits. Korean J Radiol. 2002. 3:245–253.

15. Kim TS, Lim HK, Kim H. Excessive hyperthermic necrosis of a pulmonary lobe after hypertonic saline-enhanced monopolar radiofrequency ablation. Cardiovasc Intervent Radiol. 2006. 29:160–163.

16. Sacks D, McClenny TE, Cardella JF, Lewis CA. Society of Interventional Radiology clinical practice guidelines. J Vasc Interv Radiol. 2003. 14:S199–S202.

17. Denys AL, De Baere T, Kuoch V, Dupas B, Chevallier P, Madoff DC, et al. Radio-frequency tissue ablation of the liver: in vivo and ex vivo experiments with four different systems. Eur Radiol. 2003. 13:2346–2352.

18. Burdio F, Burdio JM, Navarro A, Ros P, Guemes A, Sousa R, et al. Electric influence of NaCl concentration into the tissue in radiofrequency ablation. Radiology. 2004. 232:932.

19. Goldberg SN, Stein MC, Gazelle GS, Sheiman RG, Kruskal JB, Clouse ME. Percutaneous radiofrequency tissue ablation: optimization of pulsed-radiofrequency technique to increase coagulation necrosis. J Vasc Interv Radiol. 1999. 10:907–916.

20. Goldberg SN, Solbiati L, Hahn PF, Cosman E, Conrad JE, Fogle R, et al. Large volume tissue ablation with radiofrequency by using a clustered, internally cooled electrode technique: laboratory and clinical experience in liver metastases. Radiology. 1998. 209:371–379.

21. Solbiati L, Ierace T, Goldberg SN, Sironi S, Livraghi T, Fiocca R, et al. Percutaneous US-guided radiofrequency tissue ablation of liver metastases: treatment and follow up in 16 patients. Radiology. 1997. 202:195–203.

22. Rossi S, Garbagnati F, Lencioni R, Allgaier HP, Marchiano A, Fornari F, et al. Percutaneous radio-frequency thermal ablation of non-resectable hepatocellular carcinoma after occlusion of tumor blood supply. Radiology. 2000. 217:119–126.

23. Berber E, Flesher NL, Siperstein AE. Initial clinical evaluation of the RITA 5-centimeter radiofrequency thermal ablation catheter in the treatment of liver tumors. Cancer J Sci Am. 2000. 6:S319–S329.

24. Livraghi T, Goldberg SN, Monti F, Bizzini A, Lazzaroni S, Meloni F, et al. Saline-enhanced radio-frequency tissue ablation in the treatment of liver metastases. Radiology. 1997. 202:205–210.

25. Hoey MF, Mulier P, Shake JG. Intramural ablation using radiofrequency energy via screw-tip catheter and saline electrode. Pacing Clin Electrophysiol. 1995. 18:917.

26. Ymagami T, Iida S, Kato T, Tanaka O, Nishimura T. Combining fine-needle aspiration and core biopsy under CT fluoroscopy guidance: a better way to treat patients with lung nodules? AJR Am J Roentgenol. 2003. 180:811–815.

27. Ohno Y, Hatabu H, Takenaka D, Higashino T, Watanabe H, Ohbayashi C, et al. CT-guided transthoracic needle aspiration biopsy of small (< or = 20 mm) solitary pulmonary nodules. AJR Am J Roentgenol. 2003. 180:1665–1669.

28. Lee JM, Youk JH, Kim YK, Han YM, Chung GH, Lee SY, et al. Radio-frequency thermal ablation with hypertonic saline solution injection of the lung: ex vivo and in vivo feasibility studies. Eur Radiol. 2003. 13:2540–2547.